The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment

por Eshwaraiah, Mallikarjuna Siraganahalli, Gunda, Aparna, Kanakasetty, Govind Babu, Bakre, Manjiri M.
Publicado 2023

A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast

por Gunda, Aparna, Eshwaraiah, Mallikarjuna S., Gangappa, Kiran, Kaur, Taranjot, Bakre, Manjiri M.
Publicado 2022

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

por Gunda, Aparna, Basavaraj, Chetana, Serkad V, Chandra Prakash, Adinarayan, Manjula, Kolli, Ramu, Siraganahalli Eshwaraiah, Mallikarjuna, Saura, Cristina, Ruiz, Fiorella, Gomez, Patricia, Peg, Vicente, Jimenez, Jose, Sprung, Susanne, Fiegl, Heidi, Brunner, Christine, Egle, Daniel, Bhattacharyya, GS, Bakre, Manjiri M
Publicado 2022

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial

por Zhang, Xi, Gunda, Aparna, Kranenbarg, Elma Meershoek-Klein, Liefers, Gerrit-Jan, Savitha, Badada Ananthamurthy, Shrivastava, Payal, Serkad, Chandra Prakash Vijay Kumar, Kaur, Taranjot, Eshwaraiah, Mallikarjuna Siraganahalli, Tollenaar, Rob A. E. M., van de Velde, Cornelis J. H., Seynaeve, Caroline M. J., Bakre, Manjiri, Kuppen, Peter J. K.
Publicado 2023